Quality Gaps Target LZI’s adherence to GMP, ISO 13485 and 21 CFR 820 as a pathway to discuss potential regulatory-compliance consulting, audits, and documentation services that could streamline customer-facing audits and supplier qualification for clients.

Diagnostics Expansion Leverage their focus on in vitro diagnostic reagents for drugs of abuse to propose partnerships or white-label manufacturing opportunities, as well as expansion into additional panels or companion diagnostic tools for evolving toxicology workflows.

SMB to Mid With a workforce in the 51-200 range and revenue in the mid millions, position LZI for scalable collaborations in contract manufacturing, quality systems outsourcing, and technical support services tailored to growing clinical diagnostics programs.

Geographic Compliance Capitalize on their need to meet EU IVDD CMDCAS and other regulatory standards by offering global market access services, regulatory intelligence, and cross-border quality management solutions that ease international product registrations.

Tech & Ops Offer digital transformation and cloud-based quality management, serialization, and traceability tools compatible with ISO 13485 and GMP frameworks to improve product lifecycle management, documentation control, and supplier/customer communications.